White Papers

12.17.20

Oregon Public Option Report: An Evaluation and Comparison of Proposed Delivery Models

Section 9 of Oregon State Senate Bill 770 (SB 770), signed into law in 2019, directed the state of Oregon to engage in an analysis to help policymakers develop policy around a public option or Medicaid buy-in model for Oregon.




12.16.20

National Roadmap on State-Level Efforts to End the Nation's Drug Overdose Epidemic

Building on their 2019 “National Roadmap on State-Level Efforts to End the Opioid Epidemic: Leading-Edge Practices and Next Steps,” the American Medical Association and Manatt Health have partnered to create a new policy roadmap to combat the drug overdose epidemic.




12.15.20

Technology Opportunities for the ACA Marketplaces

Technological innovation has always been at the center of the Affordable Care Act (ACA) Marketplaces and has never been more important than it is now.




12.03.20

Caring for the Whole Child: A New Way to Finance Initiatives to Improve Children’s Health

A growing recognition that socioeconomic factors affect health outcomes in significant ways is fueling new community investments and change in healthcare delivery systems.




11.25.20

State Strategies for Overcoming Barriers to Advance Health Equity

The COVID-19 pandemic has highlighted long-standing health inequities that have resulted in an increased risk of sickness and death for people of color.




11.12.20

How Losing the Affordable Care Act Could Undo Years of Progress in the Medicaid Program

All eyes and ears were focused on the Supreme Court as it heard arguments in California v. Texas, the case challenging the constitutionality of the Affordable Care Act.




11.05.20

Moving to the Vanguard on Pediatric Care: Recommendations for the MassHealth 1115 Waiver Renewal

The COVID-19 pandemic and the spotlight on racial inequities have exposed and intensified the immense pressure on Massachusetts’ families, making this a critical time to remake and strengthen MassHealth, the combined CHIP and Medicaid program in Massachusetts, to support the ...




10.30.20

Stable Rates Reflect Strength of ACA Marketplaces

The start of the 2021 rate review process for the Affordable Care Act (ACA) Marketplaces coincided with the initial outbreak of COVID-19 cases, and early forecasts were ominous, with projections of rate increases as high as 40 percent.




10.27.20

What Is the Legislative Landscape for State Drug Affordability Boards?

As federal legislative efforts to reform prescription drug pricing have stalled and states have felt increasing pressure on their healthcare budgets, a growing number are implementing or considering prescription drug affordability review boards or commissions to reduce drug spending.




10.22.20

How States Are Advancing Whole-Person Health for People with Medicaid

As the COVID-19 crisis has shown, the ability to lead a healthy life is influenced by a multitude of factors beyond medical care.